Cleocin: Potent Antibiotic for Serious Bacterial Infections
Similar products
Cleocin (clindamycin) is a lincosamide antibiotic prescribed for the treatment of a wide range of serious anaerobic and aerobic bacterial infections. It is a critical therapeutic agent in both hospital and outpatient settings, valued for its efficacy against gram-positive bacteria and certain anaerobic organisms. Available in oral, topical, and injectable formulations, Cleocin provides clinicians with a versatile tool to combat complex infections when penicillin-class antibiotics are unsuitable or ineffective. Its ability to penetrate bone and abscesses makes it particularly valuable in deep-seated infections.
Features
- Active Ingredient: Clindamycin phosphate or clindamycin hydrochloride
- Drug Class: Lincosamide antibiotic
- Available Forms: Oral capsules (150 mg, 300 mg), topical solution/gel/foam/lotion (1%), vaginal cream (2%), injectable solution (150 mg/mL)
- Mechanism of Action: Binds to the 50S ribosomal subunit, inhibiting bacterial protein synthesis
- Spectrum of Activity: Effective against aerobic gram-positive cocci (including some methicillin-resistant Staphylococci) and anaerobic bacteria
- Bioavailability: Approximately 90% for oral formulation (not affected by food)
- Half-life: 2-3 hours (prolonged in patients with severe hepatic impairment)
Benefits
- Broad-spectrum coverage against both aerobic and anaerobic pathogens, reducing the need for combination antibiotic therapy
- Excellent tissue penetration, including bone, abscess cavities, and phagocytic cells, ensuring effective drug delivery to infection sites
- Multiple administration routes allowing for tailored treatment approaches based on infection severity and location
- Proven efficacy in treating serious infections including intra-abdominal infections, pelvic inflammatory disease, and bone/joint infections
- Alternative for penicillin-allergic patients when appropriate based on susceptibility testing
- Well-established safety profile with decades of clinical use and extensive post-marketing surveillance data
Common use
Cleocin is commonly prescribed for serious infections caused by susceptible anaerobic bacteria including Bacteroides fragilis, Fusobacterium species, and Clostridium perfringens. It is frequently used for abdominal infections, pelvic inflammatory disease, septicemia, and lower respiratory tract infections. The topical formulation is indicated for acne vulgaris, while the vaginal cream treats bacterial vaginosis. In dental contexts, it may be prescribed for odontogenic infections. Off-label uses include prophylaxis against bacterial endocarditis in penicillin-allergic patients undergoing dental procedures and treatment of babesiosis in combination with quinine.
Dosage and direction
Oral administration: Adults: 150-450 mg every 6 hours; Children: 8-25 mg/kg/day divided into 3-4 equal doses Topical application: Apply thin film to affected area twice daily Vaginal cream: One applicatorful (5 grams) intravaginally at bedtime for 7 consecutive days Injectable formulation: Serious infections: 600-2700 mg/day IV/IM divided into 2-4 doses; More severe infections may require up to 4800 mg daily Dosage adjustments required for patients with hepatic impairment. Oral capsules should be taken with a full glass of water to minimize esophageal irritation. Complete the full course of therapy even if symptoms improve to prevent antibiotic resistance.
Precautions
Clindamycin therapy has been associated with Clostridium difficile-associated diarrhea (CDAD), which may range from mild diarrhea to fatal colitis. Evaluate patients who present with diarrhea during or after treatment. Use with caution in patients with gastrointestinal disease, particularly colitis. Hepatic function monitoring is advised during prolonged therapy. May cause skin reactions ranging from mild maculopapular rash to severe cutaneous adverse reactions. Topical application may cause contact dermatitis. Vaginal cream formulation may weaken latex condoms and diaphragms. Use during pregnancy only if clearly needed; excreted in breast milk.
Contraindications
Hypersensitivity to clindamycin, lincomycin, or any component of the formulation. History of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. Concomitant use with erythromycin due to potential antagonism. Not for intrathecal, intrapleural, or intraperitoneal administration of injectable form. Do not apply topical formulations to abraded or broken skin. Vaginal cream contraindicated in patients with known hypersensitivity to soy products.
Possible side effect
Common: Nausea, vomiting, abdominal pain, diarrhea, rash, itching, metallic taste Serious: Clostridium difficile-associated diarrhea, pseudomembranous colitis, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), hepatitis, jaundice, neutropenia, eosinophilia, agranulocytosis, thrombocytopenia, anaphylaxis, polyarthritis Topical: Dryness, peeling, itching, burning, erythema, oiliness Vaginal: Vulvovaginal irritation, itching, discharge Injectable: Pain, induration, sterile abscess at injection site, thrombophlebitis with IV administration
Drug interaction
Erythromycin: Antagonistic antibacterial effect Neuromuscular blocking agents: May enhance neuromuscular blockade Opioid analgesics: May delay clindamycin absorption Kaolin-pectin: Decreases clindamycin absorption (separate administration by at least 2 hours) Cyclosporine: May increase cyclosporine levels Oral contraceptives: Possible decreased efficacy (use alternative contraception during vaginal cream therapy)
Missed dose
Take the missed dose as soon as remembered, unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing intervals to ensure consistent antibiotic levels. If multiple doses are missed, contact healthcare provider for guidance. For topical and vaginal formulations, resume regular application schedule.
Overdose
Symptoms may include severe nausea, vomiting, abdominal pain, and diarrhea. Hemodialysis and peritoneal dialysis are not effective in removing clindamycin. Management is supportive with attention to electrolyte balance and monitoring for CDAD. In case of topical overdose, wash affected area thoroughly. For vaginal overdose, discontinue use and consult healthcare provider. Contact poison control center (1-800-222-1222) for latest guidance.
Storage
Store at controlled room temperature (20-25°C/68-77°F). Oral capsules: Keep container tightly closed. Protect from light and moisture. Injectable solution: Store vials at room temperature; diluted solutions stable for 16 days at room temperature or 32 days refrigerated. Topical formulations: Keep away from heat and flame (especially foam formulation). Vaginal cream: Store at room temperature; do not freeze. Keep all medications out of reach of children and pets. Properly discard expired or unused medication.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Individual response to medication may vary. Always consult with a qualified healthcare professional before starting, changing, or stopping any medication. The prescribing physician should be aware of the patient’s complete medical history and current medications. This product requires a prescription and should be used only under medical supervision.
Reviews
“Cleocin has been a cornerstone in our surgical prophylaxis protocol for patients with penicillin allergy. Its bone penetration makes it invaluable for orthopedic procedures.” - Infectious Disease Specialist, 15 years experience
“Our dermatology practice frequently prescribes clindamycin topical solution for moderate acne with excellent results and good patient tolerance.” - Board-Certified Dermatologist
“While effective, we maintain heightened vigilance for C. difficile with any clindamycin course. Appropriate patient selection and monitoring are crucial.” - Hospital Pharmacist
“Vaginal cream formulation provides effective treatment for bacterial vaginosis with complete resolution of symptoms in most patients within the treatment course.” - OB/GYN Specialist
“The injectable form has saved numerous patients with serious intra-abdominal infections when other antibiotics failed. A truly essential antibiotic in our arsenal.” - General Surgeon